These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7691506)

  • 1. Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? (Part I).
    Herrman JP; Hermans WR; Vos J; Serruys PW
    Drugs; 1993 Jul; 46(1):18-52. PubMed ID: 7691506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel approaches for the prevention of restenosis.
    Gruberg L; Waksman R; Satler LF; Pichard AD; Kent KM
    Expert Opin Investig Drugs; 2000 Nov; 9(11):2555-78. PubMed ID: 11060820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? (Part II).
    Herrman JP; Hermans WR; Vos J; Serruys PW
    Drugs; 1993 Aug; 46(2):249-62. PubMed ID: 7691514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology and pharmacological approaches for prevention of coronary artery restenosis following coronary artery balloon angioplasty and related procedures.
    Landzberg BR; Frishman WH; Lerrick K
    Prog Cardiovasc Dis; 1997; 39(4):361-98. PubMed ID: 9050821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of restenosis after percutaneous transluminal coronary angioplasty: the search for a "magic bullet".
    Hermans WR; Rensing BJ; Strauss BH; Serruys PW
    Am Heart J; 1991 Jul; 122(1 Pt 1):171-87. PubMed ID: 2063736
    [No Abstract]   [Full Text] [Related]  

  • 6. [Restenosis after percutaneous transluminal angioplasty: II. Possibilities for pharmacologic intervention].
    Böger RH; Bode-Böger SM; Alfke H
    Vasa; 1996; 25(1):21-31. PubMed ID: 8851262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Restenosis after coronary balloon angioplasty: the clinical problem].
    da Luz PL; Solimene MC
    Rev Assoc Med Bras (1992); 1997; 43(4):357-66. PubMed ID: 9595752
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical trials of restenosis after coronary angioplasty.
    Popma JJ; Califf RM; Topol EJ
    Circulation; 1991 Sep; 84(3):1426-36. PubMed ID: 1884465
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of restenosis after coronary angioplasty: towards a molecular approach?
    Feldman LJ; Riessen R; Steg PG
    Fundam Clin Pharmacol; 1995; 9(1):8-16. PubMed ID: 7768490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of antiplatelet drug use in preventing restenosis following percutaneous transluminal coronary angioplasty.
    Cox JL; Gotlieb AI
    Can J Cardiol; 1988 May; 4(4):201-10. PubMed ID: 2456140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical promise of calcium antagonists in the angioplasty patient.
    Thaulow E; Jörgensen B
    Eur Heart J; 1997 May; 18 Suppl B():B21-6. PubMed ID: 9152666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical approaches to prevention of restenosis after coronary angioplasty.
    Blackshear JL; O'Callaghan WG; Califf RM
    J Am Coll Cardiol; 1987 Apr; 9(4):834-48. PubMed ID: 2951423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restenosis, the Achilles' heel of coronary angioplasty.
    Wurdeman RL; Hilleman DE; Mooss AN
    Pharmacotherapy; 1998; 18(5):1024-40. PubMed ID: 9758313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Restenosis after PTCA].
    Heidland UE; Michel CJ; Heintzen MP; Strauer BE
    Dtsch Med Wochenschr; 1998 Jul; 123(27):840-6. PubMed ID: 9685844
    [No Abstract]   [Full Text] [Related]  

  • 15. [Restenosis after coronary angioplasty: its pathogenesis and prevention].
    Marzocchi A; Marrozzini C; Piovaccari G; Fattori R; Castriota F; D'Anniballe G; Branzi A; Magnani B
    Cardiologia; 1991 Dec; 36(12 Suppl 1):309-20. PubMed ID: 1841786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary management of coronary heart disease.
    Menown IB
    J R Coll Physicians Edinb; 2010 Mar; 40(1):44-7; quiz 48. PubMed ID: 21125040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of a prothrombotic state in restenotic patients?
    Brack MJ; More RS; Pringle S; Gershlick AH
    Coron Artery Dis; 1994 Jun; 5(6):501-6. PubMed ID: 7952409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of intravascular stents as delivery devices to prevent restenosis.
    Pearce BJ; McKinsey JF
    Vasc Endovascular Surg; 2003; 37(4):231-7; discussion 237. PubMed ID: 12894364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty.
    Ip JH; Fuster V; Israel D; Badimon L; Badimon J; Chesebro JH
    J Am Coll Cardiol; 1991 May; 17(6 Suppl B):77B-88B. PubMed ID: 2016486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet activation and coronary interventions.
    Kutryk MJ; Serruys PW
    Eur Heart J; 1996 Aug; 17(8):1134-6. PubMed ID: 8869848
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.